These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 26794396)

  • 1. MicroRNA-based control of tick-borne flavivirus neuropathogenesis: Challenges and perspectives.
    Teterina NL; Maximova OA; Kenney H; Liu G; Pletnev AG
    Antiviral Res; 2016 Mar; 127():57-67. PubMed ID: 26794396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stable and Highly Immunogenic MicroRNA-Targeted Single-Dose Live Attenuated Vaccine Candidate against Tick-Borne Encephalitis Constructed Using Genetic Backbone of Langat Virus.
    Tsetsarkin KA; Maximova OA; Liu G; Kenney H; Teterina NL; Pletnev AG
    mBio; 2019 Apr; 10(2):. PubMed ID: 31015334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tick-borne Langat/mosquito-borne dengue flavivirus chimera, a candidate live attenuated vaccine for protection against disease caused by members of the tick-borne encephalitis virus complex: evaluation in rhesus monkeys and in mosquitoes.
    Pletnev AG; Bray M; Hanley KA; Speicher J; Elkins R
    J Virol; 2001 Sep; 75(17):8259-67. PubMed ID: 11483771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insertion of microRNA targets into the flavivirus genome alters its highly neurovirulent phenotype.
    Heiss BL; Maximova OA; Pletnev AG
    J Virol; 2011 Feb; 85(4):1464-72. PubMed ID: 21123372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA targeting of neurotropic flavivirus: effective control of virus escape and reversion to neurovirulent phenotype.
    Heiss BL; Maximova OA; Thach DC; Speicher JM; Pletnev AG
    J Virol; 2012 May; 86(10):5647-59. PubMed ID: 22419812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Construction and characterization of chimeric tick-borne encephalitis/dengue type 4 viruses.
    Pletnev AG; Bray M; Huggins J; Lai CJ
    Proc Natl Acad Sci U S A; 1992 Nov; 89(21):10532-6. PubMed ID: 1438242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of live and inactivated tick-borne encephalitis virus vaccines for safety, immunogenicity and efficacy in rhesus monkeys.
    Rumyantsev AA; Chanock RM; Murphy BR; Pletnev AG
    Vaccine; 2006 Jan; 24(2):133-43. PubMed ID: 16115704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative neuropathogenesis and neurovirulence of attenuated flaviviruses in nonhuman primates.
    Maximova OA; Ward JM; Asher DM; St Claire M; Finneyfrock BW; Speicher JM; Murphy BR; Pletnev AG
    J Virol; 2008 Jun; 82(11):5255-68. PubMed ID: 18353947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Attenuation of the Langat tick-borne flavivirus by chimerization with mosquito-borne flavivirus dengue type 4.
    Pletnev AG; Men R
    Proc Natl Acad Sci U S A; 1998 Feb; 95(4):1746-51. PubMed ID: 9465088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergistic Internal Ribosome Entry Site/MicroRNA-Based Approach for Flavivirus Attenuation and Live Vaccine Development.
    Tsetsarkin KA; Liu G; Volkova E; Pletnev AG
    mBio; 2017 Apr; 8(2):. PubMed ID: 28420742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Infectious cDNA clone of attenuated Langat tick-borne flavivirus (strain E5) and a 3' deletion mutant constructed from it exhibit decreased neuroinvasiveness in immunodeficient mice.
    Pletnev AG
    Virology; 2001 Apr; 282(2):288-300. PubMed ID: 11289811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcriptional Response to Tick-Borne Flavivirus Infection in Neurons, Astrocytes and Microglia In Vivo and In Vitro.
    Rosendal E; Lindqvist R; Chotiwan N; Henriksson J; Överby AK
    Viruses; 2024 Aug; 16(8):. PubMed ID: 39205301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kissing-loop interaction between 5' and 3' ends of tick-borne Langat virus genome 'bridges the gap' between mosquito- and tick-borne flaviviruses in mechanisms of viral RNA cyclization: applications for virus attenuation and vaccine development.
    Tsetsarkin KA; Liu G; Shen K; Pletnev AG
    Nucleic Acids Res; 2016 Apr; 44(7):3330-50. PubMed ID: 26850640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A tick-borne Langat virus mutant that is temperature sensitive and host range restricted in neuroblastoma cells and lacks neuroinvasiveness for immunodeficient mice.
    Rumyantsev AA; Murphy BR; Pletnev AG
    J Virol; 2006 Feb; 80(3):1427-39. PubMed ID: 16415020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cross-reactive antibodies against Langat virus protect mice from lethal tick-borne encephalitis virus infection.
    Kubinski M; Beicht J; Zdora I; Saletti G; Kircher M; Petry-Gusmag M; Steffen I; Puff C; Jung K; Baumgärtner W; Rimmelzwaan GF; Osterhaus ADME; Prajeeth CK
    Front Immunol; 2023; 14():1134371. PubMed ID: 36926332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IRE1-Mediated Unfolded Protein Response Promotes the Replication of Tick-Borne Flaviviruses in a Virus and Cell-Type Dependent Manner.
    Breitkopf VJM; Dobler G; Claus P; Naim HY; Steffen I
    Viruses; 2021 Oct; 13(11):. PubMed ID: 34834970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Concurrent micro-RNA mediated silencing of tick-borne flavivirus replication in tick vector and in the brain of vertebrate host.
    Tsetsarkin KA; Liu G; Kenney H; Hermance M; Thangamani S; Pletnev AG
    Sci Rep; 2016 Sep; 6():33088. PubMed ID: 27620807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exosomes serve as novel modes of tick-borne flavivirus transmission from arthropod to human cells and facilitates dissemination of viral RNA and proteins to the vertebrate neuronal cells.
    Zhou W; Woodson M; Neupane B; Bai F; Sherman MB; Choi KH; Neelakanta G; Sultana H
    PLoS Pathog; 2018 Jan; 14(1):e1006764. PubMed ID: 29300779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety evaluation of chimeric Langat/Dengue 4 flavivirus, a live vaccine candidate against tick-borne encephalitis.
    Pripuzova NS; Tereshkina NV; Gmyl LV; Dzhivanyan TI; Rumyantsev AA; Romanova LIu; Mustafina AN; Lashkevich VA; Karganova GG
    J Med Virol; 2009 Oct; 81(10):1777-85. PubMed ID: 19697399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the Langat/dengue 4 chimeric virus as a live attenuated tick-borne encephalitis vaccine for safety and immunogenicity in healthy adult volunteers.
    Wright PF; Ankrah S; Henderson SE; Durbin AP; Speicher J; Whitehead SS; Murphy BR; Pletnev AG
    Vaccine; 2008 Feb; 26(7):882-90. PubMed ID: 18207289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.